Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

ProAmatine (Midodrine Hydrochloride) Tablets
Company:  Shire Laboratories Inc.
Application No.:  19-815/S5
Approval Date: 3/20/2002


Date created: May 14, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.